Showing 401 - 420 results of 3,726 for search '(( significant increase decrease ) OR ( significance ((we decrease) OR (a decrease)) ))~', query time: 0.53s Refine Results
  1. 401

    Basic information of retrieved datasets. by Li-Hong Chen (610826)

    Published 2025
    “…A serials of bioinformatics analysis, including batch normalization, differential analysis, and single-cell sequencing analysis were finished through R software. …”
  2. 402

    POriginal blots. by Li-Hong Chen (610826)

    Published 2025
    “…A serials of bioinformatics analysis, including batch normalization, differential analysis, and single-cell sequencing analysis were finished through R software. …”
  3. 403

    PTable S4 Expression validation of CYP1B1. by Li-Hong Chen (610826)

    Published 2025
    “…A serials of bioinformatics analysis, including batch normalization, differential analysis, and single-cell sequencing analysis were finished through R software. …”
  4. 404

    PTable S2 Differentially expressed genes. by Li-Hong Chen (610826)

    Published 2025
    “…A serials of bioinformatics analysis, including batch normalization, differential analysis, and single-cell sequencing analysis were finished through R software. …”
  5. 405

    PTable S5 Markers of each cell cluster. by Li-Hong Chen (610826)

    Published 2025
    “…A serials of bioinformatics analysis, including batch normalization, differential analysis, and single-cell sequencing analysis were finished through R software. …”
  6. 406

    Gene expression omnibus datasets. by Xinyi Xia (7516694)

    Published 2024
    “…Functional enrichment analysis revealed that inflammation played a significant role. Based on shared genes, TCMR was divided into two clusters. …”
  7. 407

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…”
  8. 408

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…”
  9. 409

    Clinical characteristics. by Clemens Plattner (21567706)

    Published 2025
    “…FHD was associated with increased risk for neuropathy (HR 1.41 [95%CI 1.11–1.81]) but decreased risk for macrovascular disease (HR 0.84 [95%CI 0.71–0.99]). …”
  10. 410

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  11. 411

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  12. 412

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  13. 413

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  14. 414

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  15. 415

    Implementation framework. by Amos Asiedu (4996946)

    Published 2025
    “…HMIS data showed statistically significant improvement in data completeness (from 62 to 87% (p < 0.001)) and decreased error rate (from 37 to 18% (p < 0.001)) after completion of the coaching visit series. …”
  16. 416

    DHIMS2 data quality over time. by Amos Asiedu (4996946)

    Published 2025
    “…HMIS data showed statistically significant improvement in data completeness (from 62 to 87% (p < 0.001)) and decreased error rate (from 37 to 18% (p < 0.001)) after completion of the coaching visit series. …”
  17. 417

    The Influence of Nucleating Agent Positional Isomer Structure on the Nucleation Efficiency of Poly(lactic acid): Interaction-Induced Conformational Transitions under High Lattice M... by Jingbo Wu (328587)

    Published 2025
    “…The results demonstrate that 2ODPTA (with hydroxyl groups at the ortho position) exhibits the highest nucleating activity. At a loading level of 0.5 wt %, 2ODPTA significantly increases the crystallization peak temperature to 121.5 °C, whereas as the hydroxyl substitution shifts from the ortho position to the para position, the temperature decreases to 108.2 and 105.8 °C, respectively. …”
  18. 418

    The Influence of Nucleating Agent Positional Isomer Structure on the Nucleation Efficiency of Poly(lactic acid): Interaction-Induced Conformational Transitions under High Lattice M... by Jingbo Wu (328587)

    Published 2025
    “…The results demonstrate that 2ODPTA (with hydroxyl groups at the ortho position) exhibits the highest nucleating activity. At a loading level of 0.5 wt %, 2ODPTA significantly increases the crystallization peak temperature to 121.5 °C, whereas as the hydroxyl substitution shifts from the ortho position to the para position, the temperature decreases to 108.2 and 105.8 °C, respectively. …”
  19. 419

    Baseline characteristics. by Seung Min Lee (1644409)

    Published 2025
    “…The distance of the FD decreased (<i>P</i> < 0.001) and FVs increased (<i>P</i> < 0.001, both). …”
  20. 420

    Data file used in this study. by Seung Min Lee (1644409)

    Published 2025
    “…The distance of the FD decreased (<i>P</i> < 0.001) and FVs increased (<i>P</i> < 0.001, both). …”